|
|
Volumn 53, Issue 3, 2001, Pages 259-265
|
|
A phase II trial of temozolomide for patients with recurrent or progressive brain metastases
a
|
|
Author keywords
Brain metastases; Chemotherapy; Lung cancer; Temozolomide
|
|
Indexed keywords
TEMOZOLOMIDE;
ADULT;
AGED;
ARTICLE;
BRAIN METASTASIS;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER CONTROL;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE CLASSIFICATION;
DISEASE COURSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
ENDOMETRIUM CANCER;
FEMALE;
HEMATOLOGIC DISEASE;
HUMAN;
LEUKOPENIA;
LIVER DISEASE;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
MALE;
MELANOMA;
OVARY CANCER;
PHASE 2 CLINICAL TRIAL;
PNEUMONIA;
RECTUM CANCER;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, ALKYLATING;
BRAIN NEOPLASMS;
CARCINOMA, NON-SMALL-CELL LUNG;
DACARBAZINE;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
SURVIVAL ANALYSIS;
TOMOGRAPHY, X-RAY COMPUTED;
|
|
EID: 0034763862
PISSN: 0167594X
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1012226718323 Document Type: Article |
|
Times cited : (211)
|
|
References (15)
|
